Home

Concord Biotech Ltd PB Ratio

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PB

13.4

Last updated on: 22 Nov 24

Key Highlights

  • The latest PB Ratio of Concord Biotech Ltd is 13.4.
  • The PB ratio of the Concord Biotech Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Concord Biotech Ltd changed from 10.4 on March 2024 to 10.4 on March 2024 . This represents a CAGR of 0.00% over 1 years.

Historical P/B Ratio of Concord Biotech Ltd

No data available

Company Fundamentals for Concord Biotech Ltd

Market Cap

21,253 Cr

EPS

31.4

P/E Ratio (TTM)

64.8

P/B Ratio (TTM)

13.4

Day’s High

2049.85

Day’s Low

1959.2

DTE

0.0

ROE

20.6

52 Week High

2658.0

52 Week Low

1221.0

ROCE

27.8

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242031.55
21 Nov 20241988.55
19 Nov 20241898.5
18 Nov 20241910.05
14 Nov 20241893.25

SWOT Analysis Of Concord Biotech Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Concord Biotech Ltd

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/B Ratio

Company
leftPBright
Concord Biotech Ltd13.36
Sun Pharmaceuticals Industries Ltd98.3
Divis Laboratories Ltd513.6
Cipla Ltd360.7
Torrent Pharmaceuticals Ltd222.4

Historical Market Cap of Concord Biotech Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Concord Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

FAQs for PB Ratio of Concord Biotech Ltd

What is the PB ratio of Concord Biotech Ltd?

The current PB ratio of Concord Biotech Ltd is 13.36. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Concord Biotech Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Concord Biotech Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Concord Biotech Ltd calculated?

The PB ratio of Concord Biotech Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Concord Biotech Ltd?

A high PB ratio suggests that Concord Biotech Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Concord Biotech Ltd?

A low PB ratio of Concord Biotech Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Concord Biotech Ltd PB Ratio change over time?

Yes, the PB ratio of Concord Biotech Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*